Science and Technology Research Institutes

The Albert B. Sabin Vaccine Institute, Inc.

Improving lives through immunization

aka Sabin Vaccine Institute   |   Washington, DC   |  www.sabin.org

Mission

Our mission is to make vaccines more accessible, enable innovation and expand immunization across the globe.

We seek a future free from vaccine-preventable diseases.

We deliver sustainable, evidence-based solutions that extend the benefits of immunization to everyone, everywhere.

Ruling year info

1994

Chief Executive Officer

Amy Finan

Main address

2175 K Street NW Suite 400

Washington, DC 20037 USA

Show more addresses

EIN

06-1389829

Cause area (NTEE code) info

Research Institutes and/or Public Policy Analysis (U05)

Specifically Named Diseases Research (H80)

Public Health Program (E70)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2018, 2017 and 2016.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Vaccines are one of the most successful health innovations in recent history, but the world is failing to reap the full benefits of immunization.

Childhood vaccination saves up to 3 million lives every year, but 1.5 million people still die each year from diseases that could have been prevented by vaccines.

Immunization is a best buy in global health, with a return of $16 for every $1 spent on immunization for the world's poorest children. When we account for broader economic and social benefits, the return on investment is much greater — up to 44 times the cost of vaccination.

Despite the enormous health and economic potential of vaccines, the world is failing to ensure everyone benefits from the promise of vaccines. One in seven children are missing out on basic vaccines. Now is the time to support countries to establish sustainable immunization programs to reach every child.

Successful immunization programs are the foundation of health care in every country in the world.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Access & Uptake

Sabin partners with low- and middle-income countries to strengthen policy, secure financing and build political will for immunization. Sabin seeks to help countries establish long-term immunization financing and policy solutions that strengthen and protect immunization systems for generations to come. Sabin is an adviser, a convener and a catalyst of systemic change, bringing together researchers, national government officials and immunization specialists at all levels to support the introduction and expansion of new and under-utilized vaccines. Through our international scientific meetings, Sabin fosters dialogue between global health leaders, researchers and implementers to unify global efforts to accelerate access to new and under-utilized vaccines. Sabin supports surveillance programs and conducts research to generate essential epidemiological data for well-designed and efficiently implemented immunization programs. By establishing and sharing best practices, we help countries evaluate and streamline vaccine introduction and scale-up.

Population(s) Served
General/Unspecified
Budget
$5,290,000

Sabin drives meaningful, well-informed conversations on emerging and established issues across the field of immunization and provides training and education on the latest in vaccine science and policy to immunization professionals, journalists and vaccine scientists. Sabin connects immunization professionals with the resources they need to overcome barriers to vaccination and improve vaccine uptake and coverage in their countries. Our scientific meetings, trainings and workshops provide professionals with the skills and tools to strengthen their countries’ vaccine research capabilities, foster vaccination program resiliency and implement successful immunization campaigns. Sabin works to shape the vaccine conversation by amplifying reliable information on vaccines. We serve as a leading voice on critical issues in global immunization, including vaccine confidence, vaccine safety and global health innovation. We also work to drive more effective, accurate media coverage on vaccines by equipping journalists with the latest information on disease burden and immunization.

Population(s) Served
General/Unspecified
Budget
$1,130,000

The Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin leverages the expertise of partners in the academic, public and private sectors, and promotes open-source research. Sabin evaluated opportunities to support vaccine development for diseases that have been overlooked despite posing a threat to billions of people. We identified a number of promising vaccine candidates and are exploring partnerships to continue development of these much-needed vaccines.

Population(s) Served
General/Unspecified
Budget
$516,000

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of countries with active Sustainable Immunization Financing presence

This metric is no longer tracked.
Totals By Year
Related Program

Access & Uptake

Context Notes

Sabin’s Sustainable Immunization Financing (SIF) Program enables countries to take long-term financial ownership over their immunization programs.

Total number of organization members

This metric is no longer tracked.
Totals By Year
Related Program

Knowledge & Innovation

Context Notes

Sabin’s International Association of Immunization Managers (IAIM) Network is the largest international network of immunization managers, offering opportunities to connect, share knowledge and strength

Charting impact

SOURCE: Self-reported by organization

Five powerful questions that require reflection about what really matters - results.

What is the organization aiming to accomplish?

Lasting solutions cannot be imposed; they must be built. That is why we are dedicated to the development of country-driven, evidence-based responses to the world's leading health problems. At Sabin, we believe in the power of vaccines to change the world. We seek a future free from vaccine-preventable diseases. We deliver sustainable, evidence-based solutions that extend the benefits of immunization to everyone, everywhere. We carry on the legacy of Dr. Albert B. Sabin, best known for his creation of the oral polio vaccine in the 1950s, which was used in the global effort to eradicate polio. His vaccine saved countless millions around the world from death and disability, thanks to Dr. Sabin's tireless commitment to ensure that every child was protected from preventable disease. This dedication to reach every child with life-saving vaccines continues to inspire our work today.

Vaccine Access & Uptake Sabin is an adviser, a convener and a catalyst of systemic change at the country and global level to strengthen policy, secure financing and build political will. We partner with low- and middle-income countries to inform long-term, country-led solutions that strengthen and protect immunization systems for generations to come. Vaccine Knowledge & Innovation Sabin provides training and education on the latest in vaccine science and policy to immunization professionals, journalists and scientists, equipping health professionals to build vaccine confidence in their regions, and launched the world's largest network of immunization managers. Vaccine Research & Development Sabin partners with other leaders to research and explore new scientific approaches to identify innovative solutions, Focusing on infectious and emerging diseases that have high human impact but may lack traditional market incentives.

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.<br/><br/>Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases.<br/><br/>As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of immunization to all people, regardless of who they are or where they live.

Sabin is a small organization whose efforts make a large impact. Robust system of monitoring & evaluation output, not just effort seek feedback from attendees

The IAIM Network is the largest international network of immunization managers to connect with peers, share knowledge, and strengthen technical and managerial skills with immunization professionals from more than 100 countries. Sabin's organizes an annual vaccinology training course; more than 240 immunization professionals from 19 countries have had the opportunity to learn from some of the world's leading experts. Sabin held three regional workshops in 2017 focused on promoting adolescent health and immunization with health professionals from across the Middle East and North Africa To promote more effective coverage of immunization in mainstream and social media, Sabin conducts workshops for journalists. In 2017, Sabin successfully supported transitions from Gavi support to national ownership in numerous countries including Madagascar, Kenya, Senegal and the DRC. Our landmark surveillance study established the burden of typhoid and paratyphoid in Bangladesh, Nepal and Pakistan.

Financials

The Albert B. Sabin Vaccine Institute, Inc.
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

The Albert B. Sabin Vaccine Institute, Inc.

Board of directors
as of 10/26/2018
SOURCE: Self-reported by organization
Board chair

Dr. Axel Hoos

GlaxoSmithKline

Axel Hoos

Glaxo Smith Kline Pharmaceuticals

Philip Russell

Medical Researcher, Educator

Peter Thoren

Access Industries

Michael Marine

Sabin Vaccine Institute

Paul Maddon

Progenics Pharmaceuticals, Inc

Regina Rabinovich

Harvard University

Wendy Holman

Ridgeback Biotherapeutics

Kenneth Kelley

White House Presidential Executive Fellow, and Senior Advisor to BARDA and NIH

Keywords

immunization, vaccine, global health, public health, vaccine access, vaccine development, coalition, rotavirus, rubella, dengue, typhoid